Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOX1 | Q06278 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3614902 | 0.77 | AOX1 (0.49) | AOX1 | |
| SCHEMBL4812026 | 0.75 | — | — | |
| SCHEMBL4951096 | 0.74 | — | — | |
| SCHEMBL4819681 | 0.74 | — | — | |
| SCHEMBL3625004 | 0.73 | ALDH1A1 (0.39) | AOX1 | |
| SCHEMBL13498165 | 0.73 | PKM (0.36) | — | |
| SCHEMBL9712303 | 0.72 | ALDH1A1 (0.43) | AOX1 | |
| SCHEMBL3623160 | 0.72 | — | — | |
| SCHEMBL776510 | 0.71 | LPAR2 (0.35) | — | |
| SCHEMBL29093968 | 0.70 | LPAR2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795464-B2 | Method for producing α-amino acid including phosphorus and production intermediates thereof | MEIJI SEIKA KAISHA LTD. (JP) | 2010-09-14 | — | — | US | disclosed |
| US-20090270647-A1 | METHOD FOR PRODUCING ALPHA - AMINO ACID INCLUDING PHOSPHORUS AND PRODUCTION INTERMEDIATES THEREOF | MEIJI SEIKA KAISHA LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| EP-2065391-A1 | METHOD FOR PRODUCING PHOSPHORUS-CONTAINING -AMINO ACID AND PRODUCTION INTERMEDIATE THEREOF | MEIJI SEIKA KAISHA LTD. (JP) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270647-A1 | METHOD FOR PRODUCING ALPHA - AMINO ACID INCLUDING PHOSPHORUS AND PRODUCTION INTERMEDIATES THEREOF | BCAT1, BCAT2, DAO | AOX1 693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.